Alzheimer’s disease in family practice
| dc.contributor.author | Greeff, Oppel Bernhardt Wilhelm | |
| dc.contributor.email | oppel.greeff@up.ac.za | en_US |
| dc.date.accessioned | 2009-11-26T06:15:28Z | |
| dc.date.available | 2009-11-26T06:15:28Z | |
| dc.date.issued | 2009-09 | |
| dc.description.abstract | 21 September 2009 is hailed as World Alzheimer's Day, creating awareness for the most common type of all the dementias. Senile dementia of the Alzheimer's type (SDAT) has a four to five year survival rate if a patient is living in the community and a much shorter survival rate for institutionalised patients. The family practitioner is often consulted first by family members who seek advice for a family member with suspected dementia and possibly Alzheimer's disease. Although a multi-disciplinary team approach is mostly needed, the family practitioner will in most cases co-ordinate referrals and advise family members on practical nursing aspects and decisions about institutionalisation. This article gives a short overview on SDAT, a classification of drugs used in dementia and a treatment approach to Alzheimer-specific pharmacotherapy. | en_US |
| dc.identifier.citation | Greeff, OBW 2009, 'Alzheimer's disease in family practice', South African Family Practice, vol. 51, no. 5, pp. 364, 366-367. [www.safpj.co.za] | en_US |
| dc.identifier.issn | 1726-426X | |
| dc.identifier.uri | http://hdl.handle.net/2263/12046 | |
| dc.language.iso | en | en_US |
| dc.publisher | OpenJournals | en_US |
| dc.rights | © 2009. The Author. Licensee: OpenJournals Publishing. This work is licensed under the Creative Commons Attribution License. | en_US |
| dc.subject | World Alzheimer's Day | en |
| dc.subject.lcsh | Alzheimer's disease -- Patients -- Care | en |
| dc.subject.lcsh | Senile dementia -- Chemotherapy | en |
| dc.subject.lcsh | Inmates of institutions | en |
| dc.subject.lcsh | Family nursing | en |
| dc.title | Alzheimer’s disease in family practice | en_US |
| dc.type | Article | en_US |
